 | • レポートコード：MRC2-11QY04308 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はポイントオブケア診断（POCD）のグローバル市場について調査・分析したレポートです。種類別（ブドウ糖検査、Hb1Ac検査、感染症検査、凝固、生殖能力、心臓マーカー、プライマリケアシステム、血液学、分散型臨床化学、糞便）市場規模、用途別（クリニック、病院、アシスティッドリビングヘルスケア施設、実験室）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ポイントオブケア診断（POCD）の競争状況、市場シェア ・世界のポイントオブケア診断（POCD）市場：種類別市場規模 2015年-2020年（ブドウ糖検査、Hb1Ac検査、感染症検査、凝固、生殖能力、心臓マーカー、プライマリケアシステム、血液学、分散型臨床化学、糞便） ・世界のポイントオブケア診断（POCD）市場：種類別市場規模予測 2021年-2026年（ブドウ糖検査、Hb1Ac検査、感染症検査、凝固、生殖能力、心臓マーカー、プライマリケアシステム、血液学、分散型臨床化学、糞便） ・世界のポイントオブケア診断（POCD）市場：用途別市場規模 2015年-2020年（クリニック、病院、アシスティッドリビングヘルスケア施設、実験室） ・世界のポイントオブケア診断（POCD）市場：用途別市場規模予測 2021年-2026年（クリニック、病院、アシスティッドリビングヘルスケア施設、実験室） ・北米のポイントオブケア診断（POCD）市場分析：米国、カナダ ・ヨーロッパのポイントオブケア診断（POCD）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのポイントオブケア診断（POCD）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のポイントオブケア診断（POCD）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのポイントオブケア診断（POCD）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Abbott、BioMérieux、Abaxis、Siemens Healthineers、QIAGEN、Danaher、Instrumentation Laboratory、Nova Biomedical、Quidel、Trinity Biotech、Sekisui Diagnostics、OraSure Technologies、Johnson & Johnson、Becton Dickinson ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Point of care tests, also called near-patient testing or bedside testing, refers to the performance of diagnostic tests at or near the site where the patient is located and helps in obtaining accurate results in a very short period of time.
Market Analysis and Insights: Global Point of Care Diagnostics (POCD) Market
The global Point of Care Diagnostics (POCD) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Point of Care Diagnostics (POCD) Scope and Market Size
Point of Care Diagnostics (POCD) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Point of Care Diagnostics (POCD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche
Abbott
BioMérieux
Abaxis
Siemens Healthineers
QIAGEN
Danaher
Instrumentation Laboratory
Nova Biomedical
Quidel
Trinity Biotech
Sekisui Diagnostics
OraSure Technologies
Johnson & Johnson
Becton Dickinson
Market segment by Type, the product can be split into
Glucose Testing
Hb1Ac Testing
Infectious Disease Testing
Coagulation
Fertility
Cardiac markers
Primary care systems
Hematology
Decentralized Clinical Chemistry
Feces
Market segment by Application, split into
Clinics
Hospitals
Assisted Living Healthcare Facilities
Laboratory
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Point of Care Diagnostics (POCD) Revenue
1.4 Market by Type
1.4.1 Global Point of Care Diagnostics (POCD) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Glucose Testing
1.4.3 Hb1Ac Testing
1.4.4 Infectious Disease Testing
1.4.5 Coagulation
1.4.6 Fertility
1.4.7 Cardiac markers
1.4.8 Primary care systems
1.4.9 Hematology
1.4.10 Decentralized Clinical Chemistry
1.4.11 Feces
1.5 Market by Application
1.5.1 Global Point of Care Diagnostics (POCD) Market Share by Application: 2020 VS 2026
1.5.2 Clinics
1.5.3 Hospitals
1.5.4 Assisted Living Healthcare Facilities
1.5.5 Laboratory
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Diagnostics (POCD) Market Perspective (2015-2026)
2.2 Global Point of Care Diagnostics (POCD) Growth Trends by Regions
2.2.1 Point of Care Diagnostics (POCD) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Point of Care Diagnostics (POCD) Historic Market Share by Regions (2015-2020)
2.2.3 Point of Care Diagnostics (POCD) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Point of Care Diagnostics (POCD) Market Growth Strategy
2.3.6 Primary Interviews with Key Point of Care Diagnostics (POCD) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Diagnostics (POCD) Players by Market Size
3.1.1 Global Top Point of Care Diagnostics (POCD) Players by Revenue (2015-2020)
3.1.2 Global Point of Care Diagnostics (POCD) Revenue Market Share by Players (2015-2020)
3.1.3 Global Point of Care Diagnostics (POCD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Point of Care Diagnostics (POCD) Market Concentration Ratio
3.2.1 Global Point of Care Diagnostics (POCD) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Point of Care Diagnostics (POCD) Revenue in 2019
3.3 Point of Care Diagnostics (POCD) Key Players Head office and Area Served
3.4 Key Players Point of Care Diagnostics (POCD) Product Solution and Service
3.5 Date of Enter into Point of Care Diagnostics (POCD) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Type (2015-2020)
4.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Point of Care Diagnostics (POCD) Market Size by Application (2015-2020)
5.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Point of Care Diagnostics (POCD) Market Size (2015-2020)
6.2 Point of Care Diagnostics (POCD) Key Players in North America (2019-2020)
6.3 North America Point of Care Diagnostics (POCD) Market Size by Type (2015-2020)
6.4 North America Point of Care Diagnostics (POCD) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Point of Care Diagnostics (POCD) Market Size (2015-2020)
7.2 Point of Care Diagnostics (POCD) Key Players in Europe (2019-2020)
7.3 Europe Point of Care Diagnostics (POCD) Market Size by Type (2015-2020)
7.4 Europe Point of Care Diagnostics (POCD) Market Size by Application (2015-2020)
8 China
8.1 China Point of Care Diagnostics (POCD) Market Size (2015-2020)
8.2 Point of Care Diagnostics (POCD) Key Players in China (2019-2020)
8.3 China Point of Care Diagnostics (POCD) Market Size by Type (2015-2020)
8.4 China Point of Care Diagnostics (POCD) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Point of Care Diagnostics (POCD) Market Size (2015-2020)
9.2 Point of Care Diagnostics (POCD) Key Players in Japan (2019-2020)
9.3 Japan Point of Care Diagnostics (POCD) Market Size by Type (2015-2020)
9.4 Japan Point of Care Diagnostics (POCD) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Point of Care Diagnostics (POCD) Market Size (2015-2020)
10.2 Point of Care Diagnostics (POCD) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Point of Care Diagnostics (POCD) Market Size by Type (2015-2020)
10.4 Southeast Asia Point of Care Diagnostics (POCD) Market Size by Application (2015-2020)
11 India
11.1 India Point of Care Diagnostics (POCD) Market Size (2015-2020)
11.2 Point of Care Diagnostics (POCD) Key Players in India (2019-2020)
11.3 India Point of Care Diagnostics (POCD) Market Size by Type (2015-2020)
11.4 India Point of Care Diagnostics (POCD) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Point of Care Diagnostics (POCD) Market Size (2015-2020)
12.2 Point of Care Diagnostics (POCD) Key Players in Central & South America (2019-2020)
12.3 Central & South America Point of Care Diagnostics (POCD) Market Size by Type (2015-2020)
12.4 Central & South America Point of Care Diagnostics (POCD) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Point of Care Diagnostics (POCD) Introduction
13.1.4 Roche Revenue in Point of Care Diagnostics (POCD) Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Abbott
13.2.1 Abbott Company Details
13.2.2 Abbott Business Overview
13.2.3 Abbott Point of Care Diagnostics (POCD) Introduction
13.2.4 Abbott Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
13.2.5 Abbott Recent Development
13.3 BioMérieux
13.3.1 BioMérieux Company Details
13.3.2 BioMérieux Business Overview
13.3.3 BioMérieux Point of Care Diagnostics (POCD) Introduction
13.3.4 BioMérieux Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
13.3.5 BioMérieux Recent Development
13.4 Abaxis
13.4.1 Abaxis Company Details
13.4.2 Abaxis Business Overview
13.4.3 Abaxis Point of Care Diagnostics (POCD) Introduction
13.4.4 Abaxis Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
13.4.5 Abaxis Recent Development
13.5 Siemens Healthineers
13.5.1 Siemens Healthineers Company Details
13.5.2 Siemens Healthineers Business Overview
13.5.3 Siemens Healthineers Point of Care Diagnostics (POCD) Introduction
13.5.4 Siemens Healthineers Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
13.5.5 Siemens Healthineers Recent Development
13.6 QIAGEN
13.6.1 QIAGEN Company Details
13.6.2 QIAGEN Business Overview
13.6.3 QIAGEN Point of Care Diagnostics (POCD) Introduction
13.6.4 QIAGEN Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
13.6.5 QIAGEN Recent Development
13.7 Danaher
13.7.1 Danaher Company Details
13.7.2 Danaher Business Overview
13.7.3 Danaher Point of Care Diagnostics (POCD) Introduction
13.7.4 Danaher Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
13.7.5 Danaher Recent Development
13.8 Instrumentation Laboratory
13.8.1 Instrumentation Laboratory Company Details
13.8.2 Instrumentation Laboratory Business Overview
13.8.3 Instrumentation Laboratory Point of Care Diagnostics (POCD) Introduction
13.8.4 Instrumentation Laboratory Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
13.8.5 Instrumentation Laboratory Recent Development
13.9 Nova Biomedical
13.9.1 Nova Biomedical Company Details
13.9.2 Nova Biomedical Business Overview
13.9.3 Nova Biomedical Point of Care Diagnostics (POCD) Introduction
13.9.4 Nova Biomedical Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
13.9.5 Nova Biomedical Recent Development
13.10 Quidel
13.10.1 Quidel Company Details
13.10.2 Quidel Business Overview
13.10.3 Quidel Point of Care Diagnostics (POCD) Introduction
13.10.4 Quidel Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
13.10.5 Quidel Recent Development
13.11 Trinity Biotech
10.11.1 Trinity Biotech Company Details
10.11.2 Trinity Biotech Business Overview
10.11.3 Trinity Biotech Point of Care Diagnostics (POCD) Introduction
10.11.4 Trinity Biotech Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
10.11.5 Trinity Biotech Recent Development
13.12 Sekisui Diagnostics
10.12.1 Sekisui Diagnostics Company Details
10.12.2 Sekisui Diagnostics Business Overview
10.12.3 Sekisui Diagnostics Point of Care Diagnostics (POCD) Introduction
10.12.4 Sekisui Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
10.12.5 Sekisui Diagnostics Recent Development
13.13 OraSure Technologies
10.13.1 OraSure Technologies Company Details
10.13.2 OraSure Technologies Business Overview
10.13.3 OraSure Technologies Point of Care Diagnostics (POCD) Introduction
10.13.4 OraSure Technologies Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
10.13.5 OraSure Technologies Recent Development
13.14 Johnson & Johnson
10.14.1 Johnson & Johnson Company Details
10.14.2 Johnson & Johnson Business Overview
10.14.3 Johnson & Johnson Point of Care Diagnostics (POCD) Introduction
10.14.4 Johnson & Johnson Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
10.14.5 Johnson & Johnson Recent Development
13.15 Becton Dickinson
10.15.1 Becton Dickinson Company Details
10.15.2 Becton Dickinson Business Overview
10.15.3 Becton Dickinson Point of Care Diagnostics (POCD) Introduction
10.15.4 Becton Dickinson Revenue in Point of Care Diagnostics (POCD) Business (2015-2020)
10.15.5 Becton Dickinson Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Point of Care Diagnostics (POCD) Key Market Segments
Table 2. Key Players Covered: Ranking by Point of Care Diagnostics (POCD) Revenue
Table 3. Ranking of Global Top Point of Care Diagnostics (POCD) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Point of Care Diagnostics (POCD) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Glucose Testing
Table 6. Key Players of Hb1Ac Testing
Table 7. Key Players of Infectious Disease Testing
Table 8. Key Players of Coagulation
Table 9. Key Players of Fertility
Table 10. Key Players of Cardiac markers
Table 11. Key Players of Primary care systems
Table 12. Key Players of Hematology
Table 13. Key Players of Decentralized Clinical Chemistry
Table 14. Key Players of Feces
Table 15. Global Point of Care Diagnostics (POCD) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Point of Care Diagnostics (POCD) Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Point of Care Diagnostics (POCD) Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Point of Care Diagnostics (POCD) Market Share by Regions (2015-2020)
Table 19. Global Point of Care Diagnostics (POCD) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Point of Care Diagnostics (POCD) Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Point of Care Diagnostics (POCD) Market Growth Strategy
Table 25. Main Points Interviewed from Key Point of Care Diagnostics (POCD) Players
Table 26. Global Point of Care Diagnostics (POCD) Revenue by Players (2015-2020) (Million US$)
Table 27. Global Point of Care Diagnostics (POCD) Market Share by Players (2015-2020)
Table 28. Global Top Point of Care Diagnostics (POCD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Diagnostics (POCD) as of 2019)
Table 29. Global Point of Care Diagnostics (POCD) by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Point of Care Diagnostics (POCD) Product Solution and Service
Table 32. Date of Enter into Point of Care Diagnostics (POCD) Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) (Million US$)
Table 35. Global Point of Care Diagnostics (POCD) Market Size Share by Type (2015-2020)
Table 36. Global Point of Care Diagnostics (POCD) Revenue Market Share by Type (2021-2026)
Table 37. Global Point of Care Diagnostics (POCD) Market Size Share by Application (2015-2020)
Table 38. Global Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) (Million US$)
Table 39. Global Point of Care Diagnostics (POCD) Market Size Share by Application (2021-2026)
Table 40. North America Key Players Point of Care Diagnostics (POCD) Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Point of Care Diagnostics (POCD) Market Share (2019-2020)
Table 42. North America Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) (Million US$)
Table 43. North America Point of Care Diagnostics (POCD) Market Share by Type (2015-2020)
Table 44. North America Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) (Million US$)
Table 45. North America Point of Care Diagnostics (POCD) Market Share by Application (2015-2020)
Table 46. Europe Key Players Point of Care Diagnostics (POCD) Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Point of Care Diagnostics (POCD) Market Share (2019-2020)
Table 48. Europe Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Point of Care Diagnostics (POCD) Market Share by Type (2015-2020)
Table 50. Europe Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Point of Care Diagnostics (POCD) Market Share by Application (2015-2020)
Table 52. China Key Players Point of Care Diagnostics (POCD) Revenue (2019-2020) (Million US$)
Table 53. China Key Players Point of Care Diagnostics (POCD) Market Share (2019-2020)
Table 54. China Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) (Million US$)
Table 55. China Point of Care Diagnostics (POCD) Market Share by Type (2015-2020)
Table 56. China Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) (Million US$)
Table 57. China Point of Care Diagnostics (POCD) Market Share by Application (2015-2020)
Table 58. Japan Key Players Point of Care Diagnostics (POCD) Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Point of Care Diagnostics (POCD) Market Share (2019-2020)
Table 60. Japan Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Point of Care Diagnostics (POCD) Market Share by Type (2015-2020)
Table 62. Japan Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Point of Care Diagnostics (POCD) Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Point of Care Diagnostics (POCD) Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Point of Care Diagnostics (POCD) Market Share (2019-2020)
Table 66. Southeast Asia Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Point of Care Diagnostics (POCD) Market Share by Type (2015-2020)
Table 68. Southeast Asia Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Point of Care Diagnostics (POCD) Market Share by Application (2015-2020)
Table 70. India Key Players Point of Care Diagnostics (POCD) Revenue (2019-2020) (Million US$)
Table 71. India Key Players Point of Care Diagnostics (POCD) Market Share (2019-2020)
Table 72. India Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) (Million US$)
Table 73. India Point of Care Diagnostics (POCD) Market Share by Type (2015-2020)
Table 74. India Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) (Million US$)
Table 75. India Point of Care Diagnostics (POCD) Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Point of Care Diagnostics (POCD) Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Point of Care Diagnostics (POCD) Market Share (2019-2020)
Table 78. Central & South America Point of Care Diagnostics (POCD) Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Point of Care Diagnostics (POCD) Market Share by Type (2015-2020)
Table 80. Central & South America Point of Care Diagnostics (POCD) Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Point of Care Diagnostics (POCD) Market Share by Application (2015-2020)
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche Product
Table 85. Roche Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (Million US$)
Table 86. Roche Recent Development
Table 87. Abbott Company Details
Table 88. Abbott Business Overview
Table 89. Abbott Product
Table 90. Abbott Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (Million US$)
Table 91. Abbott Recent Development
Table 92. BioMérieux Company Details
Table 93. BioMérieux Business Overview
Table 94. BioMérieux Product
Table 95. BioMérieux Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (Million US$)
Table 96. BioMérieux Recent Development
Table 97. Abaxis Company Details
Table 98. Abaxis Business Overview
Table 99. Abaxis Product
Table 100. Abaxis Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (Million US$)
Table 101. Abaxis Recent Development
Table 102. Siemens Healthineers Company Details
Table 103. Siemens Healthineers Business Overview
Table 104. Siemens Healthineers Product
Table 105. Siemens Healthineers Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (Million US$)
Table 106. Siemens Healthineers Recent Development
Table 107. QIAGEN Company Details
Table 108. QIAGEN Business Overview
Table 109. QIAGEN Product
Table 110. QIAGEN Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (Million US$)
Table 111. QIAGEN Recent Development
Table 112. Danaher Company Details
Table 113. Danaher Business Overview
Table 114. Danaher Product
Table 115. Danaher Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (Million US$)
Table 116. Danaher Recent Development
Table 117. Instrumentation Laboratory Business Overview
Table 118. Instrumentation Laboratory Product
Table 119. Instrumentation Laboratory Company Details
Table 120. Instrumentation Laboratory Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (Million US$)
Table 121. Instrumentation Laboratory Recent Development
Table 122. Nova Biomedical Company Details
Table 123. Nova Biomedical Business Overview
Table 124. Nova Biomedical Product
Table 125. Nova Biomedical Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (Million US$)
Table 126. Nova Biomedical Recent Development
Table 127. Quidel Company Details
Table 128. Quidel Business Overview
Table 129. Quidel Product
Table 130. Quidel Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (Million US$)
Table 131. Quidel Recent Development
Table 132. Trinity Biotech Company Details
Table 133. Trinity Biotech Business Overview
Table 134. Trinity Biotech Product
Table 135. Trinity Biotech Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (Million US$)
Table 136. Trinity Biotech Recent Development
Table 137. Sekisui Diagnostics Company Details
Table 138. Sekisui Diagnostics Business Overview
Table 139. Sekisui Diagnostics Product
Table 140. Sekisui Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (Million US$)
Table 141. Sekisui Diagnostics Recent Development
Table 142. OraSure Technologies Company Details
Table 143. OraSure Technologies Business Overview
Table 144. OraSure Technologies Product
Table 145. OraSure Technologies Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (Million US$)
Table 146. OraSure Technologies Recent Development
Table 147. Johnson & Johnson Company Details
Table 148. Johnson & Johnson Business Overview
Table 149. Johnson & Johnson Product
Table 150. Johnson & Johnson Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (Million US$)
Table 151. Johnson & Johnson Recent Development
Table 152. Becton Dickinson Company Details
Table 153. Becton Dickinson Business Overview
Table 154. Becton Dickinson Product
Table 155. Becton Dickinson Revenue in Point of Care Diagnostics (POCD) Business (2015-2020) (Million US$)
Table 156. Becton Dickinson Recent Development
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point of Care Diagnostics (POCD) Market Share by Type: 2020 VS 2026
Figure 2. Glucose Testing Features
Figure 3. Hb1Ac Testing Features
Figure 4. Infectious Disease Testing Features
Figure 5. Coagulation Features
Figure 6. Fertility Features
Figure 7. Cardiac markers Features
Figure 8. Primary care systems Features
Figure 9. Hematology Features
Figure 10. Decentralized Clinical Chemistry Features
Figure 11. Feces Features
Figure 12. Global Point of Care Diagnostics (POCD) Market Share by Application: 2020 VS 2026
Figure 13. Clinics Case Studies
Figure 14. Hospitals Case Studies
Figure 15. Assisted Living Healthcare Facilities Case Studies
Figure 16. Laboratory Case Studies
Figure 17. Point of Care Diagnostics (POCD) Report Years Considered
Figure 18. Global Point of Care Diagnostics (POCD) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 19. Global Point of Care Diagnostics (POCD) Market Share by Regions: 2020 VS 2026
Figure 20. Global Point of Care Diagnostics (POCD) Market Share by Regions (2021-2026)
Figure 21. Porter's Five Forces Analysis
Figure 22. Global Point of Care Diagnostics (POCD) Market Share by Players in 2019
Figure 23. Global Top Point of Care Diagnostics (POCD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Diagnostics (POCD) as of 2019
Figure 24. The Top 10 and 5 Players Market Share by Point of Care Diagnostics (POCD) Revenue in 2019
Figure 25. North America Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Europe Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. China Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Japan Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Southeast Asia Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. India Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Central & South America Point of Care Diagnostics (POCD) Market Size YoY Growth (2015-2020) (Million US$)
Figure 32. Bottom-up and Top-down Approaches for This Report
Figure 33. Data Triangulation
Figure 34. Key Executives Interviewed
ポイントオブケア凝固検査の世界市場（～2026年） POCT, also called near-patient testing, is performed outside a clinical laboratory. The increasing penetration of POCT devices in developed countries is one of the significant factors driving the growth of this market. Market Analysis and Insights: Global Point-of-Care Coagulation Testing Market The…- ポイントオブケア診断の世界市場（～2026年） Market Analysis and Insights: Global Point-of-Care Diagnostics Market The global Point-of-Care Diagnostics market size is projected to reach US$ 24030 million by 2026, from US$ 22640 million in 2020, at a CAGR of 5.7%% during 2021-2026. Global Point-of-Care Diagnostics Scope and Market Size Point-of…
- ポイントオブケア感染症診断の世界市場（～2026年） Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment. The point-of-care infectious disease diagnostics market is expected to register a fast growth over the forecast period owing to the emerging trend of patient-centric se…
- 心臓ポイントオブケア（POC）の世界市場（～2026年） Cardiac POC is a medical test performed to diagnose patients. The cardiac POCs are blood tests including cholesterol and coagulation testing. These include brain natriuretic peptide tests and troponin. Troponin are used to analyse various cardiovascular conditions such as coronary syndromes, heart f…
- ポイントオブケア感染性疾患の世界市場（～2026年） A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management. Market Analysis and Insights: Global Point…